Chapters Transcript Video Emerging Technology in Treatment of Valvular Heart Disease Dr. Paul Mahoney, from the Structural Heart Program at Sentara, discusses new frontiers in TAVR to include new technology, new techniques and new indications. Published November 10, 2021 Created by Related Presenters Paul D. Mahoney, M.D. Cardiology Dr. Paul Mahoney serves as the Medical Director of the Sentara Structural Heart Program. He has a particular focus on the diagnosis and treatment of structural heart disease. View full profile